North America Veterinary Radiotherapy Market

North America Veterinary Radiotherapy Market & Forecast:

• North America Veterinary Radiotherapy Market Size 2025: USD 1.60 Billion
• North America Veterinary Radiotherapy Market Size 2033: USD 3.12 Billion
• North America Veterinary Radiotherapy Market CAGR: 8.79% 
• North America Veterinary Radiotherapy Market Segments: By Product Type (Linear Accelerators, Brachytherapy Systems, Treatment Planning Software, Imaging Systems, Radiation Monitoring Systems, Immobilization Devices, Service Solutions, Others); By Application (Canine Oncology, Feline Oncology, Equine Oncology, Soft Tissue Sarcoma, Brain Tumors, Nasal Tumors, Palliative Care, Others); By Technology (External Beam Radiotherapy, IMRT, SRS, Image-Guided Radiotherapy, AI-Enabled Systems, Adaptive Radiotherapy, Combination Therapy, Others); By End User (Veterinary Hospitals, Specialty Veterinary Clinics, Academic Centers, Research Institutes, Referral Centers, Mobile Veterinary Services, Cancer Centers, Others); By Distribution Channel (Direct Sales, Medical Distributors, Hospital Procurement, Leasing Services, Specialty Suppliers, Service Contracts, Dealers, Others) 

North America Veterinary Radiotherapy Market Summary

The North America Veterinary Radiotherapy Market was valued at USD 1.60 Billion in 2025. It is forecast to reach USD 3.12 Billion by 2033. That is a CAGR of 8.79% over the period.

North America Veterinary Radiotherapy Market is kind of pivotal for dealing with cancer in companion animals, because it delivers aimed radiation that takes down tumors while trying to keep the adjacent healthy tissue intact. In practice, veterinary hospitals and specialized oncology centers lean hard on radiotherapy for situations when surgery cannot remove everything, or when chemotherapy alone can’t really get it under control. Over the last five years , we’ve seen a clear shift away from more conventional radiation setups toward newer image guided and stereotactic radiotherapy platforms, and that makes the overall treatment tighter and usually reduces the total number of therapy sessions.

When COVID-19 hit, it first slowed equipment installations and even disrupted medical device supply chains, but in a bit of a confusing turn it also increased spend on specialty vet care as pet ownership climbed and wider healthcare budgets moved up across North America. On top of that, pet cancer detection is inching higher, referral networks keep expanding, and advanced oncology offerings appear more frequently. Taken together these forces nudge clinics toward radiotherapy systems purchases, and that, in turn, helps keep equipment sales stronger, supports ongoing service agreements, and supports steadier long term market income.

Key Market Insights

• North America’s veterinary radiotherapy market is forecast to reach USD 3.12 billion by 2033, which basically shows sustained investment into veterinary oncology infrastructure, and yeah it’s been steady.
• In 2025, the United States held the lead with an estimated market share of over 82% , mainly because specialty veterinary hospitals are scaling up, and advanced treatment options are more widely available.
• Canada is expected to be the fastest-growing regional market over the forecast period, as referral oncology centers keep expanding throughout several major provinces.
• External beam radiotherapy accounted for roughly 68% of the market revenue in 2025. That makes it the top product segment, largely due to clinical dependability.
• Image-guided radiotherapy is projected to see the quickest growth through 2033, supported by better treatment precision, and also smoother workflow efficiency.
• Companion animal oncology generated nearly 74% of the total application revenue in 2025, reflecting higher cancer diagnosis rates in dogs and cats.
• Veterinary specialty hospitals held an estimated around 66% market share in 2025, while academic veterinary centers are still growing their oncology research capabilities, more and more.
• Key companies such as Varian Medical Systems, Elekta AB, Accuray Incorporated, Eckert & Ziegler BEBIG, Canon Medical Systems, and Siemens Healthineers continue strengthening their veterinary oncology footprint.
• Manufacturers are building competitive strength via AI-enabled treatment planning, image-guided radiation systems, strategic collaborations with veterinary hospitals, and broader service network expansion, sort of in parallel.
• Overall, the North America veterinary radiotherapy market continues to benefit from precision medicine adoption, digital imaging integration, and higher investment in specialized veterinary cancer care.

What are the Key Drivers, Restraints, and Opportunities in the North America Veterinary Radiotherapy Market?

The strongest force behind market expansion seems to be the fast modernization of companion animal oncology, not just in theory but, in practice. Over the past several years, veterinary hospitals have been pouring in money for advanced imaging, radiation planning software, and linear accelerator technology, as pet owners keep looking for treatments that feel kinda similar to human cancer care. Also, once pet insurance gets more available, and household spending on companion animals keeps climbing, the money hurdles start to shrink for a lot of families. That means specialty clinics can more often provide intricate radiotherapy procedures. In the end, these investments keep paying off via treatment planning, imaging, follow up care, and longer term oncology services, so radiotherapy turns into a more valuable business segment for referral hospitals, pretty much across the board.

The biggest structural snag however is still the high capital investment needed to set up veterinary radiotherapy facilities. Buying radiation equipment, building shielded treatment rooms, meeting radiation safety rules, and getting board certified veterinary oncologists onboard all call for heavy financial commitments. And because of that, the infrastructure side can’t be fixed overnight, especially not in smaller markets where budgets are tight. So, many clinics stay in a referral pattern, sending patients to far away specialty centers. That can delay treatment, while also slowing equipment adoption and trimming overall market revenue.

There’s also a meaningful opportunity in blending advanced imaging, artificial intelligence, and adaptive radiotherapy directly into veterinary oncology workflows. Think of technologies like AI assisted treatment planning, plus cone beam CT guided radiation delivery, where clinicians can fine tune targeting accuracy while reducing planning time. It’s a bit like getting a faster, steadier workflow, without giving up precision, which is probably why people are paying attention to it.

What Has the Impact of Artificial Intelligence Been on the North America Veterinary Radiotherapy Market?

Artificial intelligence, plus advanced digital technologies, is kind of changing veterinary radiotherapy in a big way especially when it comes to treatment planning imaging interpretation and how fast the whole operation runs. With AI assisted contouring tools, the software can automatically point out tumors and the nearby, still healthy, tissues from CT and MRI images. Then veterinary oncologists can build more precise radiation plans with less handwork involved. Honestly, that really cuts down the planning time a lot, and somehow it makes the whole process feel less tedious, even if the details still matter. On top of that, machine learning methods tune the radiation dose layout, which means clinicians can actually hit the intended target better, while also trying to keep healthy organs exposure lower.

At the same time, advanced analytics improves predictive maintenance for linear accelerators and imaging systems , by watching how the equipment behaves. It can flag parts that might need servicing ahead of time, before they fail in some kind of sudden moment. Because of this, equipment availability tends to stay steadier, and the unplanned downtime drops. Specialty hospitals, in particular, benefit since they can keep treatment dates more consistent. Digital workflow platforms also stitch together patient imaging, treatment planning, quality assurance, and even appointment scheduling. The result is better operational efficiency, and fewer hours spent on administrative stuff that really nobody wants to do.

AI powered image registration along with adaptive treatment planning can further boost accuracy during therapy, especially if the tumor size changes or if patient positioning shifts a bit. Still, broad adoption is not fully happening yet. The bottlenecks are mostly high software integration costs, a shortage of veterinary specific training datasets, and the reality that experienced specialists must verify any AI generated recommendations. Smaller veterinary hospitals often don’t have enough financial backing or technical support to roll these systems out, so adoption stays slower even though the clinical advantages are clearly meaningful.

Key Market Trends

• From 2021 to 2025, many veterinary hospitals somehow started pouring more money into image-guided radiotherapy systems , which made treatment accuracy better while also lowering the need for repeat procedures, here and there.
• At the same time companion animal oncology referrals climbed in a steady way as dogs and cats accounted for more than 70% of oncology treatment volumes at specialty hospitals, overall.
• In advanced oncology centers that adopted digital planning software, AI-assisted radiation treatment planning cut down manual contouring time by somewhere between 20% and 40%, which is kind of a big deal.
• Manufacturers also leaned into cone-beam CT imaging integrated with radiotherapy platforms, and this helped clinicians localize tumors more precisely before basically every treatment session.
• Varian Medical Systems , Elekta AB , and Accuray Incorporated then expanded software capabilities focused on adaptive treatment planning plus workflow automation, all together.
• Veterinary specialty hospitals increasingly teamed up with academic institutions too, partly to deepen clinical research and partly to improve access to advanced cancer therapies , sooner rather than later.
• Investment shifted away from standalone radiation systems and toward fully integrated oncology platforms that combine imaging, treatment planning, and patient management software, as a package.
• In Canada, the growth of specialty veterinary oncology centers felt stronger after 2022 which improved regional access to advanced radiation treatments, without as much waiting.
• Across North America pet insurance adoption kept rising, and that helped absorb treatment costs while encouraging broader use of advanced cancer therapies.
• Lastly, equipment manufacturers were more and more focused on long-term service agreements , software upgrades, and clinical training programs , basically to boost customer retention and grow recurring revenue.

North America Veterinary Radiotherapy Market Segmentation

By Product Type

Linear accelerators still take the biggest share, partly because accurate external radiation treatment stays the go-to option for many veterinary oncology centers. Brachytherapy systems are used for only certain tumor cases, where localized radiation delivery really matters, yet their adoption stays rather limited due to the specialized equipment needs , and yes that slows things down. Treatment planning software then comes in handy for precise dose computation, treatment simulation and overall workflow coordination, which helps the oncology team tighten planning accuracy. Imaging systems give more straightforward visualization before as well as during therapy, so tumor identification and positioning can be kept on track across each individual session.

Radiation monitoring systems help keep treatment on target by measuring the delivered doses and also meeting radiation safety obligations. Immobilization devices reduce patient movement and help preserve stable positioning during every treatment session. Service solutions cover installation, maintenance, calibration, software upgrades, and technical support, all meant to keep facilities running reliably. Other offerings include support accessories and specialized equipment built for unique treatment requirements, as well as evolving clinical practices that keep changing over time.

By Application

Canine oncology shows up as the top application area, mostly because dogs get diagnosed with a relatively high number of cancer cases and they also tend to receive advanced oncology care at specialty hospitals. Feline oncology keeps growing, since better diagnostic methods now make earlier tumor detection more possible and that really broadens the range of therapies you can try. Equine oncology is still a smaller slice, largely because the overall treatment volume is lower, even if some referral centers keep providing advanced radiation therapy for horses. Soft tissue sarcoma is still a frequently seen indication, since targeted radiation can help lessen recurrence after surgical procedures so it kind of makes sense in practice.

Brain tumors are different , they need very precise treatment planning, so advanced radiotherapy becomes an important option for certain neurological cases. Nasal tumors can benefit from radiation therapy too, because actually reaching the tumor surgically can be awkward , and radiation improves disease control anyway. Palliative care is about easing pain and supporting quality of life when full tumor removal is not achievable. Other categories include several less common cancer types, these typically call for a customized treatment plan depending on tumor location , and the patient’s clinical condition.

By Technology

External beam radiotherapy is still, sort of, the main option because broad clinical acceptance and steady day-to-day treatment output back up its use across most veterinary oncology centers. Intensity Modulated Radiation Therapy, also called IMRT, helps refine dose distribution by bending the radiation beams around tricky tumor shapes while keeping nearby normal tissue at a safer distance. Stereotactic Radiosurgery (SRS) sends a very concentrated dose in fewer visits, so it can fit certain carefully screened cancer situations. Image Guided Radiotherapy, or IGRT, boosts accuracy via real-time imaging that checks the patient’s placement right before the beam is actually delivered.

AI assisted platforms support plan generation, image interpretation, and even routine flow improvements, so the clinical team can move through planning faster. Adaptive radiotherapy lets the plan adjust when the tumor evolves or when patient anatomy shifts during the treatment cycle. Combination therapy mixes radiotherapy with surgery, chemotherapy, or immunotherapy to raise the chance of better overall outcomes. Other approaches include newer technologies and specialized delivery methods that get introduced when specific clinical requirements show up.

By End User

Veterinary hospitals take the largest share because a full oncology approach , meaning comprehensive services, advanced imaging resources, and seasoned clinical teams help run the whole cancer treatment program. Specialized veterinary clinics keep growing their radiotherapy offerings by putting money into dedicated radiation equipment, plus trained staff. Academic centers add value via clinical research, expert education, and assessing newer treatment methods—this kind of work ends up reinforcing the way veterinary cancer care is delivered. Research institutes also back the process through technology development, radiation studies, and partnerships with equipment manufacturers so the next wave of treatment options can be better.

Referral centers handle the trickier cancer cases that get moved over from general veterinary practices, so there’s steady demand for advanced radiotherapy services. Mobile veterinary services stay pretty limited, since radiotherapy hardware needs permanent infrastructure, and specialized safety measures. Cancer centers tend to focus only on oncology diagnosis, treatment planning, and long term patient follow up, using modern radiation technologies. The remaining category includes private niche facilities, along with independent oncology practices that serve regional treatment demand.

By Distribution Channel

Direct sales still look like the top distribution channel, mostly because manufacturers sort of work hand in hand with veterinary hospitals during equipment choice, setup, and ongoing technical support. Medical distributors, in turn, broaden the market reach by moving equipment and related accessories across regional care networks, and at the same time they keep product availability stable. On the hospital side, procurement departments tend to buy radiotherapy systems using formal evaluation routines that try to balance technical results, service reliability, and financial planning, all together. Leasing services also show up as a different financing approach, basically so facilities can bring in cutting edge equipment without needing a big upfront capital spend.

Specialty suppliers then deliver focused oncology products replacement parts, and those clinical add-ons that are made for radiation treatment facilities. Service contracts back up preventive care, calibration, equipment inspections, and software upgrades, helping systems stay dependable over time. Dealers help in a more local way by offering regional sales support, doing product demonstrations, and managing customer service tasks. And finally, there are others, like alternative procurement arrangements, built for particular purchasing conditions across different veterinary healthcare organizations.

What are the Key Use Cases Driving the North America Veterinary Radiotherapy Market?

Cancer care in companion animals stays like the main, baseline use case thats basically backing market growth. In particular, canine oncology seems to drive the most treatment volume, mostly because dogs get tumors more often and many of them respond very well to external beam radiotherapy. As a result, veterinary hospitals plus specialist oncology centers are leaning on advanced radiation systems, not just to improve local tumor control but also to stretch survival, and keep quality of life steadier after surgery or chemotherapy ,sometimes both.

On top of that, treatment for brain tumors ,and nasal tumors is picking up momentum now. This is happening as image-guided radiotherapy and intensity-modulated approaches get easier to access across more practices. Specialty clinics and referral centers are adopting these tools more frequently, because precise targeting helps limit harm to nearby healthy tissue while still improving outcomes in those medically tricky anatomical situations.

Looking forward, new directions show up too, like adaptive radiotherapy that’s supported by artificial intelligence, and also combination protocols where radiation is integrated with immunotherapy. Academic centers, research institutes keep testing personalized planning approaches and comparative oncology programs, and that keeps opening doors for more routine clinical uptake during the forecast period.

Which Regions are Driving the North America Veterinary Radiotherapy Market Growth?

The United States tends to lead the market, mostly due to advanced veterinary healthcare infrastructure, strong companion animal healthcare spending and the broad reach of specialty oncology centers, which together make radiotherapy adoption feel kinda natural. There’s also a lot of money going into diagnostic imaging and radiation treatment equipment, so veterinary hospitals keep upgrading their technology in a fairly steady way. In addition, a solid referral center network helps the more complicated oncology cases get routed to specialized facilities that already have advanced treatment options. On top of that, collaboration between research institutions, equipment manufacturers and veterinary specialists keeps feeding innovation, and that makes clinical uptake easier too.

Canada brings in steady market revenue, supported by ongoing expansion of specialty veterinary services plus growing investment in companion animal healthcare. But market momentum here leans more on coordinated referral networks and academic partnerships, rather than on very large hospital volumes. Veterinary teaching hospitals really matter, because they introduce advanced oncology technologies and run clinical training programs that stick. With stable healthcare spending and gradual technology adoption the whole thing forms a reliable base for long-term market growth.

Mexico is the fastest-moving market right now, largely because private veterinary hospitals are still investing in more advanced cancer treatment capabilities. As urban pet ownership keeps expanding and diagnostic imaging becomes more available, access to specialized oncology care has improved a lot in the last few years. Meanwhile, international equipment suppliers keep strengthening regional distribution networks, and they also add technical support to match the rising clinical demand.

Who are the Key Players in the North America Veterinary Radiotherapy Market and How Do They Compete?

Competition still feels moderately consolidated in practice, mostly because state-of-the-art radiotherapy systems need a lot of hands-on technical know-how, plus regulatory compliance, and honestly long build cycles. In the end, purchasing people tend to care about tech leadership, treatment accuracy, how well imaging ties in, and whether the vendor can keep supporting the installed base over time. The bigger manufacturers keep doubling down on their existing equipment footprint , while veterinary imaging and diagnostic specialists keep rolling out more complementary oncology solutions that help clinicians plan better and manage patients in a more organized way.

Varian stands out with advanced linear accelerator platforms, treatment planning software that is integrated, and image-guided radiotherapy capabilities that make it easier to run more complex veterinary oncology procedures. Ongoing spend on precision treatment technologies and working together with academic cancer centers helps push real clinical adoption. Elekta , on the other hand, leans into flexible radiation delivery, adaptive treatment workflows, and high quality imaging to improve treatment accuracy while also lowering procedural friction. Their growth in AI supported planning solutions also keeps widening the product gap.

Accuray competes on highly accurate stereotactic radiation systems that are built for precise tumor targeting, with the goal of reducing spill over exposure to healthy tissue around the target. Hallmarq Veterinary Imaging , meanwhile, supports veterinary oncology through advanced imaging platforms that improve diagnosis and treatment planning before radiotherapy even starts. IDEXX Laboratories helps oncology practices through diagnostic testing, pathology services, and integrated laboratory information, all of which supports earlier cancer detection and enables more tailored treatment choices.

Company List

• Varian
• Elekta
• Accuray
• GE HealthCare
• Siemens Healthineers
• Canon Medical
• Philips
• IDEXX Laboratories
• Zoetis
• Antech Diagnostics
• Eickemeyer
• Hallmarq Veterinary Imaging
• IMV Imaging
• VetCT
• Esaote

Recent Development News

In April 2026, Colorado State University Flint Animal Cancer Center launched a new Varian Edge linear accelerator for veterinary radiation oncology. The installation improved precision treatment capabilities, enhanced imaging, and expanded comparative oncology research while strengthening advanced cancer care for companion animals.https://www.csuanimalcancercenter.org

In January 2026, Elekta received U.S. FDA 510(k) clearance for the Elekta Evo CT-Linac. The approval introduced AI-enhanced imaging and advanced treatment capabilities to the U.S. radiation oncology market, supporting future adoption in veterinary oncology applications.https://www.appliedradiationoncology.com

In April 2026, LINEV Systems announced the VETOROX veterinary radiotherapy series ahead of ESTRO 2026. The dedicated veterinary radiotherapy platform expanded technology options for animal hospitals seeking compact external beam radiation treatment systems.https://www.linevsystems.com

What Strategic Insights Define the Future of the North America Veterinary Radiotherapy Market?

The market will keep drifting toward precision oncology, supported by integrated imaging , artificial intelligence, and adaptive treatment planning over the next five to seven years. More collaboration between veterinary hospitals, academic institutions and medical technology companies will speed up adoption of advanced radiation platforms , plus it should help broaden access to specialized cancer care, maybe faster than expected. A quieter risk is that advanced treatment capacity is getting bunched up in just a handful of referral hospitals, which could end up slowing regional reach , even if revenue growth looks good on paper.

There is also a real, emerging opening in AI-assisted adaptive radiotherapy built specifically for veterinary patients , especially once those software platforms become more cost effective and backed by solid clinical validation. So, market participants might do better by investing in integrated oncology ecosystems that tie together imaging, treatment planning, diagnostics, training, and long-term service support instead of only chasing equipment sales as the main route.

North America Veterinary Radiotherapy Market Report Segmentation

By Product Type

• Linear Accelerators
• Brachytherapy Systems
• Treatment Planning Software
• Imaging Systems
• Radiation Monitoring Systems
• Immobilization Devices
• Service Solutions
• Others

By Application

• Canine Oncology
• Feline Oncology
• Equine Oncology
• Soft Tissue Sarcoma
• Brain Tumors
• Nasal Tumors
• Palliative Care
• Others

By Technology

• External Beam Radiotherapy
• Intensity-Modulated Radiation Therapy (IMRT)
• Stereotactic Radiosurgery (SRS)
• Image-Guided Radiotherapy (IGRT)
• AI-Enabled Systems
• Adaptive Radiotherapy
• Combination Therapy
• Others

By End User

• Veterinary Hospitals
• Specialty Veterinary Clinics
• Academic Centers
• Research Institutes
• Referral Centers
• Mobile Veterinary Services
• Cancer Centers
• Others

By Distribution Channel

• Direct Sales
• Medical Distributors
• Hospital Procurement
• Leasing Services
• Specialty Suppliers
• Service Contracts
• Dealers
• Others